Furthermore, if rs4810083 (T/T) activates PEPCK expression and the gluconeogenesis pathway, it may lead to persistent hyperglycemia despite metformin treatment, as gluconeogenesis remains active. This evidence concerns the gene PCK2 and Hyperglycemia.